Harrow, Inc. Selling, General and Administrative Expense
Harrow, Inc. (HROW) reported Selling, General and Administrative Expense of $53.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-10
- Harrow, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $53.30M, a 60.37% increase year-over-year.
- Harrow, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $43.23M, a 6.71% increase year-over-year.
- Harrow, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $43.31M, a 24.49% increase year-over-year.
- Harrow, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $35.86M, a 6.57% increase year-over-year.
- Harrow, Inc. selling, general and administrative expense for fiscal 2025 was $152.91M, a 18.48% increase from fiscal 2024.
- Harrow, Inc. selling, general and administrative expense for fiscal 2024 was $129.06M, a 55.33% increase from fiscal 2023.
- Harrow, Inc. selling, general and administrative expense for fiscal 2023 was $83.09M, a 42.66% increase from fiscal 2022.
- Harrow, Inc. selling, general and administrative expense for fiscal 2022 was $58.24M, a 40.97% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed | Selling, General and Administrative Expense 155 month | Selling, General and Administrative Expense 158 month | Selling, General and Administrative Expense 161 month | Selling, General and Administrative Expense 164 month | Selling, General and Administrative Expense 167 month | Selling, General and Administrative Expense 170 month | Selling, General and Administrative Expense 173 month | Selling, General and Administrative Expense 176 month | Selling, General and Administrative Expense 182 month | Selling, General and Administrative Expense 185 month | Selling, General and Administrative Expense 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $53.30M 10-Q · filed 2026-08-10 | $96.53M 10-Q · filed 2026-08-10 | $139.84M derived: sum of 3 quarters · filed 2026-08-10 | $175.69M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||
| 2026-03-31 | $43.23M 10-Q · filed 2026-05-11 | $86.54M derived: sum of 2 quarters · filed 2026-05-11 | $122.40M derived: sum of 3 quarters · filed 2026-05-11 | $155.63M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||
| 2025-12-31 | $43.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $79.17M derived: sum of 2 quarters · filed 2026-03-02 | $112.40M derived: sum of 3 quarters · filed 2026-08-10 | $152.91M 10-K · filed 2026-03-02 | ||||||||||||
| 2025-09-30 | $35.86M 10-Q · filed 2025-11-10 | $69.09M derived: sum of 2 quarters · filed 2026-08-10 | $109.60M 10-Q · filed 2025-11-10 | $144.39M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||
| 2025-06-30 | $33.23M 10-Q · filed 2026-08-10 | $73.75M 10-Q · filed 2026-08-10 | $108.54M derived: sum of 3 quarters · filed 2026-08-10 | $142.18M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||
| 2025-03-31 | $40.51M 10-Q · filed 2026-05-11 | $75.30M derived: sum of 2 quarters · filed 2026-05-11 | $108.95M derived: sum of 3 quarters · filed 2026-05-11 | $140.76M derived: sum of 4 quarters · filed 2026-05-11 | ||||||||||||
| 2024-12-31 | $34.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $68.43M derived: sum of 2 quarters · filed 2026-03-02 | $100.25M derived: sum of 3 quarters · filed 2026-03-02 | $129.06M 10-K · filed 2026-03-02 | ||||||||||||
| 2024-09-30 | $33.65M 10-Q · filed 2025-11-10 | $65.46M derived: sum of 2 quarters · filed 2025-11-10 | $94.28M 10-Q · filed 2025-11-10 | $120.49M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2024-06-30 | $31.82M 10-Q · filed 2025-08-11 | $60.63M 10-Q · filed 2025-08-11 | $86.84M derived: sum of 3 quarters · filed 2026-03-02 | $107.88M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2024-03-31 | $28.81M 10-Q · filed 2025-05-08 | $55.02M derived: sum of 2 quarters · filed 2026-03-02 | $76.06M derived: sum of 3 quarters · filed 2026-03-02 | $96.02M derived: sum of 4 quarters · filed 2026-03-02 | ||||||||||||
| 2023-12-31 | $26.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $47.24M derived: sum of 2 quarters · filed 2026-03-02 | $67.20M derived: sum of 3 quarters · filed 2026-03-02 | $83.09M 10-K · filed 2026-03-02 | ||||||||||||
| 2023-09-30 | $21.03M 10-Q · filed 2024-11-14 | $40.99M derived: sum of 2 quarters · filed 2024-11-14 | $56.88M 10-Q · filed 2024-11-14 | $72.12M derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||
| 2023-06-30 | $19.96M 10-Q · filed 2024-08-07 | $35.84M 10-Q · filed 2024-08-07 | $51.08M derived: sum of 3 quarters · filed 2024-08-07 | $66.50M derived: sum of 4 quarters · filed 2024-08-07 | ||||||||||||
| 2023-03-31 | $15.89M 10-Q · filed 2024-05-13 | $31.13M derived: sum of 2 quarters · filed 2024-05-13 | $46.55M derived: sum of 3 quarters · filed 2024-05-13 | $60.73M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||
| 2022-12-31 | $15.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $30.66M derived: sum of 2 quarters · filed 2024-03-19 | $44.84M derived: sum of 3 quarters · filed 2024-03-19 | $58.24M 10-K · filed 2024-03-19 | ||||||||||||
| 2022-09-30 | $15.42M 10-Q · filed 2023-11-13 | $29.61M derived: sum of 2 quarters · filed 2023-11-13 | $43.00M 10-Q · filed 2023-11-13 | $55.68M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||||||
| 2022-06-30 | $14.19M 10-Q · filed 2023-08-09 | $27.58M 10-Q · filed 2023-08-09 | $40.26M derived: sum of 3 quarters · filed 2023-08-09 | $51.61M derived: sum of 4 quarters · filed 2023-08-09 | ||||||||||||
| 2022-03-31 | $13.40M 10-Q · filed 2023-05-11 | $26.07M derived: sum of 2 quarters · filed 2023-05-11 | $37.43M derived: sum of 3 quarters · filed 2023-05-11 | $46.55M derived: sum of 4 quarters · filed 2023-05-11 | ||||||||||||
| 2021-12-31 | $12.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $24.03M derived: sum of 2 quarters · filed 2023-03-23 | $33.15M derived: sum of 3 quarters · filed 2023-03-23 | $41.31M 10-K · filed 2023-03-23 | ||||||||||||
| 2021-09-30 | $11.36M 10-Q · filed 2022-11-14 | $20.48M derived: sum of 2 quarters · filed 2022-11-14 | $28.64M 10-Q · filed 2022-11-14 | $36.08M derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | $9.12M 10-Q · filed 2022-08-09 | $17.29M 10-Q · filed 2022-08-09 | $24.73M derived: sum of 3 quarters · filed 2022-08-09 | $33.16M derived: sum of 4 quarters · filed 2022-08-09 | ||||||||||||
| 2021-03-31 | $8.16M 10-Q · filed 2022-05-05 | $15.61M derived: sum of 2 quarters · filed 2022-05-05 | $24.04M derived: sum of 3 quarters · filed 2022-05-05 | $31.00M derived: sum of 4 quarters · filed 2022-05-05 | ||||||||||||
| 2020-12-31 | $7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $15.88M derived: sum of 2 quarters · filed 2022-03-10 | $22.83M derived: sum of 3 quarters · filed 2022-03-10 | $31.25M 10-K · filed 2022-03-10 | ||||||||||||
| 2020-09-30 | $8.44M 10-Q · filed 2021-11-09 | $15.39M derived: sum of 2 quarters · filed 2021-11-09 | $23.81M 10-Q · filed 2021-11-09 | $31.50M derived: sum of 4 quarters · filed 2021-11-09 | ||||||||||||
| 2020-06-30 | $6.95M 10-Q · filed 2021-08-10 | $15.37M 10-Q · filed 2021-08-10 | $23.06M derived: sum of 3 quarters · filed 2021-08-10 | $31.67M derived: sum of 4 quarters · filed 2021-08-10 | ||||||||||||
| 2020-03-31 | $8.42M 10-Q · filed 2021-05-11 | $16.11M derived: sum of 2 quarters · filed 2021-05-11 | $24.71M derived: sum of 3 quarters · filed 2021-05-11 | $32.96M derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||||
| 2019-12-31 | $7.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $16.30M derived: sum of 2 quarters · filed 2021-03-08 | $24.55M derived: sum of 3 quarters · filed 2021-03-08 | $33.09M 10-K · filed 2021-03-08 | $33.10M 10-K · filed 2020-03-13 | |||||||||||
| 2019-09-30 | $8.61M 10-Q · filed 2020-11-09 | $16.86M derived: sum of 2 quarters · filed 2020-11-09 | $25.40M 10-Q · filed 2020-11-09 | $34.41M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||
| 2019-06-30 | $8.25M 10-Q · filed 2020-08-10 | $16.79M 10-Q · filed 2020-08-10 | $25.80M derived: sum of 3 quarters · filed 2020-08-10 | $32.77M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | $8.54M 10-Q · filed 2020-05-11 | $17.55M derived: sum of 2 quarters · filed 2020-05-11 | $24.52M derived: sum of 3 quarters · filed 2020-05-11 | $31.30M derived: sum of 4 quarters · filed 2020-05-11 | ||||||||||||
| 2018-12-31 | $9.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $15.98M derived: sum of 2 quarters · filed 2020-03-13 | $22.75M derived: sum of 3 quarters · filed 2020-03-13 | $29.24M 10-K · filed 2020-03-13 | ||||||||||||
| 2018-09-30 | $6.96M 10-Q · filed 2019-11-13 | $13.74M derived: sum of 2 quarters · filed 2019-11-13 | $20.23M 10-Q · filed 2019-11-13 | $26.17M derived: sum of 4 quarters · filed 2019-11-13 | ||||||||||||
| 2018-06-30 | $6.78M 10-Q · filed 2019-08-14 | $13.27M 10-Q · filed 2019-08-14 | $19.21M derived: sum of 3 quarters · filed 2019-08-14 | $24.99M derived: sum of 4 quarters · filed 2019-08-14 | ||||||||||||
| 2018-03-31 | $6.49M 10-Q · filed 2019-05-09 | $12.43M derived: sum of 2 quarters · filed 2019-05-09 | $18.21M derived: sum of 3 quarters · filed 2019-05-09 | $24.70M derived: sum of 4 quarters · filed 2019-05-09 | ||||||||||||
| 2017-12-31 | $5.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $11.72M derived: sum of 2 quarters · filed 2019-03-12 | $18.21M derived: sum of 3 quarters · filed 2019-03-12 | $25.02M 10-K · filed 2019-03-12 | ||||||||||||
| 2017-09-30 | $5.78M 10-Q · filed 2018-11-13 | $12.27M derived: sum of 2 quarters · filed 2018-11-13 | $19.08M 10-Q · filed 2018-11-13 | |||||||||||||
| 2017-06-30 | $6.49M 10-Q · filed 2018-08-06 | $13.30M 10-Q · filed 2018-08-06 | ||||||||||||||
| 2017-03-31 | $6.81M 10-Q · filed 2018-05-15 | |||||||||||||||
| 2014-03-31 | $2.28M 10-Q · filed 2014-05-15 | $4.16M derived: sum of 2 quarters · filed 2014-05-15 | $5.78M derived: sum of 3 quarters · filed 2014-05-15 | $7.34M derived: sum of 4 quarters · filed 2014-05-15 | $20.91M 10-Q · filed 2014-05-15 | |||||||||||
| 2013-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $3.50M derived: sum of 2 quarters · filed 2014-03-28 | $5.06M derived: sum of 3 quarters · filed 2014-03-28 | $6.08M 10-K · filed 2014-03-28 | $18.63M 10-K · filed 2014-03-28 | |||||||||||
| 2013-09-30 | $1.62M 10-Q · filed 2013-11-06 | $3.18M derived: sum of 2 quarters · filed 2013-11-06 | $4.20M 10-Q · filed 2013-11-06 | $4.94M derived: sum of 4 quarters · filed 2014-05-15 | $16.75M 10-Q · filed 2013-11-06 | |||||||||||
| 2013-06-30 | $1.56M 10-Q · filed 2013-08-14 | $2.58M 10-Q · filed 2013-08-14 | $3.32M derived: sum of 3 quarters · filed 2014-05-15 | $4.26M derived: sum of 4 quarters · filed 2014-05-15 | $15.13M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $1.02M 10-Q · filed 2014-05-15 | $1.76M derived: sum of 2 quarters · filed 2014-05-15 | $2.71M derived: sum of 3 quarters · filed 2014-05-15 | $3.69M derived: sum of 4 quarters · filed 2014-05-15 | $13.57M 10-Q · filed 2013-05-08 | |||||||||||
| 2012-12-31 | $740.37K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $1.69M derived: sum of 2 quarters · filed 2014-03-28 | $2.67M derived: sum of 3 quarters · filed 2014-03-28 | $2.98M 10-K · filed 2014-03-28 | $12.55M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $946.38K 10-Q · filed 2013-11-06 | $1.93M derived: sum of 2 quarters · filed 2013-11-06 | $2.24M 10-Q · filed 2013-11-06 | $2.55M derived: sum of 4 quarters · filed 2013-11-06 | $11.81M 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $984.67K 10-Q · filed 2013-08-14 | $1.29M 10-Q · filed 2013-08-14 | $1.61M derived: sum of 3 quarters · filed 2013-08-14 | $1.67M derived: sum of 4 quarters · filed 2013-08-14 | $10.87M 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $308.96K 10-Q · filed 2013-05-08 | $622.10K derived: sum of 2 quarters · filed 2013-05-08 | $688.60K derived: sum of 3 quarters · filed 2013-05-08 | $810.03K derived: sum of 4 quarters · filed 2013-05-08 | $9.88M 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $313.14K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $379.64K derived: sum of 2 quarters · filed 2013-03-18 | $501.07K derived: sum of 3 quarters · filed 2013-03-18 | $827.67K 10-K · filed 2013-03-18 | $9.57M 10-K · filed 2012-02-23 | |||||||||||
| 2011-09-30 | $66.50K 10-Q · filed 2012-11-14 | $187.93K derived: sum of 2 quarters · filed 2012-11-14 | $514.53K 10-Q · filed 2012-11-14 | $1.07M derived: sum of 4 quarters · filed 2012-11-14 | $9.26M 10-Q · filed 2012-02-23 | |||||||||||
| 2011-06-30 | $121.43K 10-Q · filed 2012-08-14 | $448.03K 10-Q · filed 2012-08-14 | $1.01M derived: sum of 3 quarters · filed 2012-08-14 | $1.59M derived: sum of 4 quarters · filed 2012-08-14 | $9.19M 10-Q · filed 2012-02-23 | |||||||||||
| 2011-03-31 | $326.60K 10-Q · filed 2012-05-10 | $884.20K derived: sum of 2 quarters · filed 2012-05-10 | $1.47M derived: sum of 3 quarters · filed 2012-05-10 | $1.88M derived: sum of 4 quarters · filed 2012-05-10 | ||||||||||||
| 2010-12-31 | $557.59K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $1.14M derived: sum of 2 quarters · filed 2012-02-23 | $1.55M derived: sum of 3 quarters · filed 2012-02-23 | $2.31M 10-K · filed 2012-02-23 | ||||||||||||
| 2010-09-30 | $584.98K 10-Q · filed 2012-02-23 | $994.79K derived: sum of 2 quarters · filed 2012-02-23 | $1.75M 10-Q · filed 2012-02-23 | |||||||||||||
| 2010-06-30 | $409.81K 10-Q · filed 2012-02-23 | $1.17M 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |